ESC Premium Access

Ventricular arrhythmias: Improved treatment and risk prediction

Event: ESC CONGRESS 2017
Topic: Ventricular arrhythmias
Session type: Moderated Posters
Date: 27 August 2017
Time: 10:05 - 10:55

Congress Session

7 presentations in this session

Ventricular arrhythmias do not affect prognosis in patients with continuous-flow left ventricular assist devices

Speaker: Doctor T. Koenig (Hannover, DE)

Long-term outcome of LAVA elimination in ablation of post-myocardial infarction ventricular tachycardia.

Speaker: Doctor M. Wolf (Antwerp, BE)

Long-term prognosis of Brugada syndrome patients with syncope

Speaker: Doctor E. Arbelo (Barcelona, ES)

Electrocardiographic algorithms to guide management strategy of outflow tract ventricular arrhythmias

Speaker: Doctor B. Ludwik (Wroclaw, PL)

Reduction of fast-VT related syncope by beta-blockers: a dose-dependent effect. Results from a multicenter study.

Speaker: Associate Professor J. Jimenez-Candil (Salamanca, ES)

Image-based criteria to identify the presence of epicardial arrhythmic substrate in patients with transmural myocardial infarction

Speaker: Doctor D. Soto-Iglesias (Barcelona, ES)

The role of MIBG scintigraphy in anticipating the occurrence of sustained ventricular arrhythmias after CRT in patients with remote monitoring

Speaker: Doctor M. Coutinho Cruz (Lisbon, PT)

7 speakers from this session

Doctor Thorben Koenig

Hannover Medical School, Hannover (Germany)
0 follower

Doctor Michael Wolf

ZNA Middelheim Hospital, Antwerp (Belgium)
0 follower

Doctor Elena Arbelo

Hospital Clinic, University of Barcelona, Barcelona (Spain)
16 presentations

Doctor Bartosz Ludwik

Regional Specialist Hospital, Research and Development Centre, Wroclaw (Poland)
0 follower

Associate Professor Javier Jimenez-Candil

IBSAL-Hospital Universitario de Salamanca, Salamanca (Spain)
0 follower

Doctor David Soto-Iglesias

centro medico Teknon, Barcelona (Spain)
0 follower

Doctor Madalena Coutinho Cruz

Hospital de Santa Marta, Lisbon (Portugal)
2 presentations
0 follower

This platform is supported by

logo Novo Nordisk